OpenAI Buys Orchestra Bio, Silent on Its Pharma Ops Customers
OpenAI is moving Orchestra Bio's drug-program agents into Rosalind and has not said whether the standalone product or its contracts survive. Customers should export their data and get continuity terms in writing.
October 22, 2026 · 8 min read